Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1991 | 06-1991 | 03-1991 | 12-1990 | 09-1990 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 9,143 | 7,386 | 10,675 | 13,993 | 8,147 |
| TOTAL | $9,143 | $7,386 | $10,675 | $13,993 | $8,147 |
| Non-Current Assets | |||||
| PPE Net | 458,434 | 454,269 | 452,113 | 449,229 | 441,504 |
| Investments And Advances | 2,813 | 3,128 | 2,942 | 2,932 | 3,123 |
| Other Non-Current Assets | 20,529 | 18,405 | 15,282 | 13,832 | 11,467 |
| TOTAL | $481,776 | $475,802 | $470,337 | $465,993 | $456,094 |
| Total Assets | $490,919 | $483,188 | $481,012 | $479,986 | $464,241 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 31,478 | 16,757 | 17,397 | 77,779 | 51,756 |
| Accounts payable and accrued liabilities | 14,629 | 15,419 | 12,202 | 20,100 | 16,291 |
| Accrued Expenses | 8,685 | 6,989 | 13,551 | 6,231 | 6,459 |
| TOTAL | $79,687 | $66,957 | $66,394 | $124,624 | $97,661 |
| Non-Current Liabilities | |||||
| TOTAL | $65,257 | $63,651 | $61,535 | $59,653 | $57,755 |
| Total Liabilities | $144,944 | $130,608 | $127,929 | $184,277 | $155,416 |
| Shareholders' Equity | |||||
| Common Shares | 108,333 | 112,399 | 114,795 | 111,360 | 111,936 |
| TOTAL | $108,333 | $112,399 | $114,795 | $111,360 | $111,936 |
| Total Liabilities And Equity | $253,277 | $243,007 | $242,724 | $295,637 | $267,352 |